Nava Center
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Ozone Therapy
Boca Raton, FL
stem cell consult rooms in Boca Raton FL sit along Glades Rd / Mizner Blvd medical corridor, Town Center drive-time suites, and I-95 Palm Beach County offices more than spa calendars. Local stem cell clinics pack cash-pay menus between primary-care referrals and drive-time longevity pitches aimed at metro and suburb patients alike. A neighboring suburb commute changes who books follow-up, not the dosing math. This hub is Boca Raton FL listings.
Stem cell marketing is not one product. Autologous vs donor sourcing, tissue type, and processing claims all change what you buy. Ask for the written protocol, not a brochure slogan.
This hub lists Directory clinics for Boca Raton FL and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask source of cells, processing claims, imaging guidance, follow-up schedule, and what happens if symptoms do not match the brochure. Local freeways shape booking windows, not the underlying biology. Prefer plain risk talk and written consent. Use the national stem cell Directory and Guide, then return here.
Before you trust badges and counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
Florida cellular therapy providers are governed by 21 CFR Part 1271. Section 361 applies to minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 applies to products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND or BLA. Most stem cell, stromal vascular fraction, exosome, umbilical cord blood derived, and culture-expanded mesenchymal cell therapies marketed in Florida for orthopedic, neurologic, autoimmune, and longevity indications fall under Section 351 and lack FDA approval. Florida is a high-volume market, which has translated into elevated federal scrutiny.
Florida has been a primary target of FDA enforcement. In US v US Stem Cell Inc (2019), a federal court in Florida granted a permanent injunction against a Sunrise-based clinic for marketing unapproved stem cell products derived from adipose tissue. The Eleventh Circuit upheld the injunction in 2021. The FDA has issued multiple warning letters to Florida clinics offering exosome and umbilical cord-derived therapies. The Florida Department of Health and the Boards of Medicine and Osteopathic Medicine have disciplined physicians for unprofessional conduct tied to misleading regenerative medicine marketing. The Florida Attorney General has pursued deceptive trade practice claims under FDUTPA against stem cell clinics.
Available here
Nationwide
Stem Cell Therapy clinics across the US